What is the ticker symbol for Vascular Biogenics?

Vascular Biogenics trades under the ticker VBLT on NASDAQ.

What sector does Vascular Biogenics operate in?

Vascular Biogenics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze VBLT in a portfolio?

PortView shows VBLT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Vascular Biogenics (VBLT) Stock Analysis

NASDAQHealthcareBiotechnology

$0.16-8.77%

1-year price historyRange $0.11 – $0.32

52-week range$0.16

$0.10$0.32

What Vascular Biogenics does

Vascular Biogenics Ltd. (VBLT) operates as a clinical-stage biopharmaceutical company, dedicated to developing therapeutic solutions for cancer and immune-inflammatory diseases. The company's activities are concentrated in Israel and the United States. Its pipeline is anchored by two core technological platforms: First, a gene-based vascular targeting system that focuses on newly formed blood vessels; and second, an antibody-based monocyte targeting technology that aims to specifically inhibit monocyte migration, particularly for immune-inflammatory applications. VBLT's flagship product candidate, VB-111, a gene-based biologic, is undergoing several clinical trials. It has reached Phase III for the treatment of recurrent, platinum-resistant ovarian cancer. Additionally, it is in Phase II trials for recurrent glioblastoma and colorectal cancer. Moreover, VB-111 has completed Phase II clinical trials for thyroid cancer. The company is also developing VB-601 for a variety of inflammatory indications and VB-611 for different types of solid tumors. Initially incorporated as Medicard Ltd. in 2000, the company rebranded as Vascular Biogenics Ltd. in January 2003. Its main offices are situated in Modi'in, Israel.

Key metrics

Market cap

$12.11M

P/E (TTM)

-0.87

EPS (TTM)

$-0.18

Beta

0.71

Dividend yield

0.00%

Revenue / share

$0.14

50-day avg

$0.23

200-day avg

$0.21

52-week high

$0.32

52-week low

$0.10

CEO

Dror Harats

ETFs linked to VBLT

Broad-market and Healthcare sector ETFs an investor holding Vascular Biogenics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how VBLT fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze VBLT in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Vascular Biogenics?: Vascular Biogenics trades under the ticker VBLT on NASDAQ.
Which exchange is VBLT listed on?: VBLT is listed on NASDAQ.
What sector does Vascular Biogenics operate in?: Vascular Biogenics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze VBLT in a portfolio?: PortView shows VBLT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.